Canadian Cancer Trials Group
Clinical trials sponsored by Canadian Cancer Trials Group, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Immunotherapy drug durvalumab tested to stop bladder cancer return Results expected Oct 2026 (estimated)
- New pill shows promise against tough breast cancer Results expected Nov 2026 (estimated)
- New immunotherapy cocktails aim to outsmart resistant ovarian cancer Results expected Dec 2026 (estimated)
- Can talk therapy and symptom tracking ease the trauma of leukemia? Results expected Dec 2026 (estimated)
- Canadian trial matches cancer drugs to gene mutations Results expected Dec 2026 (estimated)